Melrose, MA, United States of America

Brian A Elenbaas


Average Co-Inventor Count = 2.8

ph-index = 1

Forward Citations = 17(Granted Patents)


Company Filing History:


Years Active: 2008-2020

Loading Chart...
3 patents (USPTO):

Title: Brian A Elenbaas: Innovator in Cancer Therapy

Introduction

Brian A Elenbaas is a notable inventor based in Melrose, MA (US). He has made significant contributions to the field of cancer therapy through his innovative research and development. With a total of 3 patents, Elenbaas has focused on predictive biomarkers that enhance the effectiveness of cancer treatments.

Latest Patents

Elenbaas's latest patents include groundbreaking work on predictive biomarkers for hypoxia-activated prodrug therapy. One of his patents highlights that enolase levels can predict the likelihood of a cancer patient responding favorably to therapy involving hypoxia-activated achiral phosphoramide mustards. Another patent emphasizes that CYP2W1 levels serve as a predictive marker for the same type of therapy, indicating the probability of a positive response in cancer patients.

Career Highlights

Throughout his career, Brian A Elenbaas has worked with prominent companies in the biotechnology sector. He has been associated with Molecular Templates, Inc. and Biogen Idec MA Inc., where he has contributed to various innovative projects aimed at improving cancer treatment outcomes.

Collaborations

Elenbaas has collaborated with several professionals in his field, including Matthew B Jarpe and Steven Donald Miklasz. These collaborations have further enriched his research and development efforts.

Conclusion

Brian A Elenbaas stands out as an influential inventor in the realm of cancer therapy, with his patents paving the way for advancements in treatment methodologies. His work continues to impact the lives of cancer patients positively.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…